Research and development
Continually innovating to push the boundaries of human advancement in medicine
We are committed to investing broadly in innovation and development of best-in-class or first-in-class products and supporting technologies. Our current focus is within oncology and infectious diseases, but we are also exploring opportunities in novel therapeutic areas such as autoimmune disorders.
Our core technology is the Vaccibody™ platform, based on the concept of targeting antigen to Antigen Presenting Cells to create better vaccines.
Our technology platform may benefit the lives of patients across several areas of high unmet need. Our pipeline is currently focused on cancer and infectious diseases, and we have initiated research within autoimmune disorders